FactSet FDS
FactSet scores good on business quality (7.5 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What FactSet does
FactSet Research Systems provides integrated financial information and analytical applications to investment professionals globally, charging subscription fees for its desktop and data feed products. The firm focuses on expanding its core content delivery and workflow integration for institutional buy-side and sell-side clients.
- What it does best
FactSet embeds its terminals into daily institutional workflows, driving high retention. Its gross margin sits at 50.6% compared to MSCI at 83.0%, reflecting a heavier reliance on third-party content fees.
- The main risk
Client budget compression in the financial sector directly threatens subscription renewal rates, capping annual revenue growth at 6.6% as institutions scrutinize software vendor spend.
Quality, check by check
Scored against its own industry, from company filings.
Operating margins stand at 28.3% backed by a net income of $533M, demonstrating solid profitability that expands steadily as revenue scales.
Switching costs form a wide moat by locking in enterprise analysts who rely on proprietary workspace configurations, ranking in the top quartile for ROE at 25.6%.
Revenue grew to $2.5B, showing a steady growth rate of 6.6% that remains largely in line with its historical trajectory but lags faster peers.
With total debt of $1.4B against cash of $265M and free cash flow of $707M, the balance sheet supports steady shareholder returns via $611M in buybacks, getting stronger.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on FDS
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
FactSet scores good on the Cluenex quality check (7.5 of 10), measured against its own industry. Profitability is strong, moat strong, growth slow and financial health strong.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Dec 16, 2026.
See FDS today
- Today's verdict on FDS, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “FactSet (FDS)”, https://cluenex.com/stocks/fds/, data as of Oct 10, 2026.